Merck Serono, a division of German pharmaceutical giant Merck, is opening a drug development incubator in Yavne, Israel. The company will invest 10 million euros in the project, supporting the development of Israeli biotech companies. The project is led by Inter-Lab, the R&D center of Merck Serono in Israel, which has already selected a few projects from over 100 applications it received.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Startup Rings Closing Bell At Nasdaq in NYC
March 28, 2024
Israeli, US Companies Unite To Make More Milk From Mushrooms
March 27, 2024
Facebook comments